Literature DB >> 15671351

Bipolar radiofrequency ablation using wet-cooled electrodes: an in vitro experimental study in bovine liver.

Jeong Min Lee1, Joon Koo Han, Se Hyung Kim, Seung Hong Choi, Su Kyung An, Chang Jin Han, Byun Ihn Choi.   

Abstract

OBJECTIVE: Our aim was to evaluate the performance of hypertonic saline (HS)-enhanced bipolar radiofrequency ablation using wet-cooled electrodes versus monopolar radiofrequency ablation to create coagulation necrosis in explanted bovine liver.
CONCLUSION: HS-enhanced bipolar radiofrequency ablation using the wet-cooled electrodes shows better performance in creating coagulation necrosis than the monopolar mode.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15671351     DOI: 10.2214/ajr.184.2.01840391

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  4 in total

1.  Comparison of wet radiofrequency ablation with dry radiofrequency ablation and radiofrequency ablation using hypertonic saline preinjection: ex vivo bovine liver.

Authors:  Jeong Min Lee; Joon Koo Han; Se Hyung Kim; Kyung Sook Shin; Jae Young Lee; Hee Sun Park; Hurn Hur; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2004 Oct-Dec       Impact factor: 3.500

Review 2.  Tumour ablation: technical aspects.

Authors:  Gerlig Widmann; Gerd Bodner; Reto Bale
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

3.  Dual switching monopolar radiofrequency ablation using a separable clustered electrode: comparison with consecutive and switching monopolar modes in ex vivo bovine livers.

Authors:  Jeong-Hee Yoon; Jeong Min Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

4.  Monopolar radiofrequency ablation using a dual-switching system and a separable clustered electrode: evaluation of the in vivo efficiency.

Authors:  Jeong Hee Yoon; Jeong Min Lee; Eui Jin Hwang; In Pyung Hwang; Jeehyun Baek; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2014-03-07       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.